Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor control probability predictions for genetic radiotherapy.

Paul J Keall1, Guido Lammering, Peck-Sun Lin

  • 1Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA 23298-0058, USA. pjkeall@vcu.edu

International Journal of Radiation Oncology, Biology, Physics
|August 12, 2003
PubMed
Summary

Genetic radiotherapy, combining gene therapy and radiation, shows promise for improved cancer treatment. This new model predicts significant increases in tumor control probability, potentially reducing radiation doses needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the impact of key algorithm parameters and patient-specific factors on the accuracy of CT ventilation imaging.

Journal of applied clinical medical physics·2026
Same author

MRI-guided radiotherapy: is the best still to come?

Physics in medicine and biology·2026
Same author

The first experimental implementation of real-time dose-guided MLC tracking using an MRI-linac.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Cardiac device motion tracking from kilovoltage projections during stereotactic arrhythmia radioablation.

Physics and imaging in radiation oncology·2026
Same author

The Kilovoltage Intrafraction Monitoring Real-Time Prostate Cancer Image Guided Radiation Therapy Technology Journey: From Clinical Trials to Your Clinic.

International journal of radiation oncology, biology, physics·2026
Same author

Toward real-time dose-guided radiation therapy: deformable multileaf collimator tracking using motion-model-derived volumetric images in lung and liver cancer patients.

Physics in medicine and biology·2025

Area of Science:

  • Oncology
  • Radiation Oncology
  • Gene Therapy

Background:

  • Genetic radiotherapy integrates gene therapy with radiation therapy for enhanced cancer treatment.
  • Current research is transitioning from preclinical studies to clinical trials for this combined modality.
  • Prospective models are essential for evaluating the clinical benefits of genetic radiotherapy due to limited patient outcome data.

Purpose of the Study:

  • To develop and utilize a prospective mathematical model for assessing the efficacy of genetic radiotherapy.
  • To quantify the potential improvements in tumor control probability (TCP) offered by genetic radiotherapy compared to conventional radiotherapy.
  • To investigate the impact of key genetic radiotherapy parameters on treatment outcomes.

Main Methods:

Related Experiment Videos

  • An established tumor control probability (TCP) model for external beam radiotherapy was adapted for genetic radiotherapy.
  • The modified model incorporated the transduced cell fraction and the enhancement factor of these cells.
  • Parametric analyses were conducted to evaluate the influence of these variables on TCP, specifically for head-and-neck cancers.

    • Main Results:

    • The model predicts a TCP increase of up to 15% for genetic radiotherapy compared to radiotherapy alone at equivalent doses, using typical parameter values.
    • Theoretical maximum TCP increases approaching 70% are possible with enhanced transduction efficiency or significant bystander effects.
    • To maintain current TCP levels, genetic radiotherapy could allow for substantial dose reductions, ranging from 5 Gy to over 30 Gy.

    Conclusions:

    • Genetic radiotherapy demonstrates significant potential to enhance tumor control outcomes beyond conventional radiotherapy.
    • The developed prospective model provides a valuable tool for predicting and optimizing genetic radiotherapy strategies.
    • Further research and clinical validation are warranted to fully realize the benefits of this innovative cancer treatment approach.